The mechanism of bronchopulmonary dysplasia and the advancement of glucocorticoid in the prophylaxis and treatment of bronchopulmonary dysplasia
10.3760/cma.j.issn.1673-4408.2021.04.004
- VernacularTitle:支气管肺发育不良的机制及糖皮质激素的防治研究进展
- Author:
Zhaoxian ZHOU
;
Zhihui RONG
- From:
International Journal of Pediatrics
2021;48(4):231-234
- CountryChina
- Language:Chinese
-
Abstract:
Bronchopulmonary dysplasia(BPD)is the main cause of chronic respiratory diseases in preterm infants.The research on the prophylaxis and treatment of BPD has been a concern of neonatologists because of its high incidence and poor prognosis in preterm infants.Glucocorticoid is a major therapy in the treatment of BPD because the pathological changes of BPD are characterized by persistent lung inflammation.Until now, a large number of clinical studies including different types and administration methods of glucocorticoids have been conducted.Compared with other types of glucocorticoids, low-dose and short-course dexamethasone has its unique advantages in the treatment of BPD.This article reviews the role of inflammation in the pathogenesis of BPD and the research progress of glucocorticoids in the prophylaxis and treatment of BPD.
